Does ROSUVASTATIN Cause International normalised ratio increased? 87 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 87 reports of International normalised ratio increased have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.2% of all adverse event reports for ROSUVASTATIN.
87
Reports of International normalised ratio increased with ROSUVASTATIN
0.2%
of all ROSUVASTATIN reports
7
Deaths
33
Hospitalizations
How Dangerous Is International normalised ratio increased From ROSUVASTATIN?
Of the 87 reports, 7 (8.0%) resulted in death, 33 (37.9%) required hospitalization, and 24 (27.6%) were considered life-threatening.
Is International normalised ratio increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 87 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause International normalised ratio increased?
WARFARIN (5,622)
RIVAROXABAN (863)
ACETAMINOPHEN (533)
ASPIRIN (448)
APIXABAN (317)
CLOPIDOGREL BISULFATE (314)
FLUINDIONE (286)
AMIODARONE (277)
FUROSEMIDE (277)
DABIGATRAN ETEXILATE (223)
Which ROSUVASTATIN Alternatives Have Lower International normalised ratio increased Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN